AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOTRON LIMITED

0.003

0.000

Volume:521.92K

Turnover:1.57K

Market Cap:3.98M

PE:-1.91

High:0.003

Open:0.003

Low:0.003

Close:0.003

Loading ...

Overview Company News Filings

Company Profile

Company Name:

BIOTRON LIMITED

Exchange:

ASX

Establishment Date:

1999

Employees:

3

Office Location:

66 Hunter Street,Level 2,Sydney,New South Wales,Australia

Website:

http://www.biotron.com.au

Zip Code:

2000

Phone:

- -

Fax:

- -

Introduction:

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BIT.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","market":"AU","secType":"STK","nameCN":"BIOTRON LIMITED","latestPrice":0.003,"timestamp":1747116720000,"preClose":0.003,"halted":0,"volume":521917,"delay":0,"nameEN":"BIOTRON LIMITED","floatShares":1131782613,"shares":1327245843,"eps":-0.001569,"marketStatus":"Not Yet Opened","change":0,"latestTime":"05-13 16:12:00 AEST","open":0.003,"high":0.003,"low":0.003,"amount":1566,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.001569,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1747094400000,1747116000000]],"volumeRatio":1.4045038458950208,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIT.AU\",,,,,undefined,":{"symbol":"BIT.AU","floatShares":1131782613,"roa":"-51.97%","roe":"-121.67%","lyrEps":-0.003809,"volumeRatio":1.4045038458950208,"shares":1327245843,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.002,"pbRate":"8.67","psRate":"2.19","week52High":0.058,"institutionHeld":0,"latestPrice":0.003,"eps":-0.001569,"divideRate":0,"volume":521917,"delay":0,"ttmEps":-0.001569,"open":0.003,"prevYearClose":0.016,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.01},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":7658306,"yearFounded":1999,"employeeNum":3,"address":"66 Hunter Street,Level 2,Sydney,New South Wales,Australia","zipCode":"2000"},"stockCompanyDetail":{"websiteUrl":"http://www.biotron.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.5},{"period":"3month","weight":-0.6667},{"period":"6month","weight":-0.8235},{"period":"1year","weight":-0.9412},{"period":"ytd","weight":-0.8125}],"compareEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0514},{"period":"3month","weight":0.0345},{"period":"6month","weight":0.1389},{"period":"1year","weight":0.1401},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.28,"avgChangeRate":-0.06298},{"month":2,"riseRate":0.44,"avgChangeRate":-0.015344},{"month":3,"riseRate":0.24,"avgChangeRate":-0.075071},{"month":4,"riseRate":0.44,"avgChangeRate":0.047428},{"month":5,"riseRate":0.125,"avgChangeRate":-0.140956},{"month":6,"riseRate":0.583333,"avgChangeRate":0.110905},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.016245},{"month":8,"riseRate":0.25,"avgChangeRate":0.059053},{"month":9,"riseRate":0.541667,"avgChangeRate":0.150596},{"month":10,"riseRate":0.333333,"avgChangeRate":0.024497},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.002804},{"month":12,"riseRate":0.458333,"avgChangeRate":0.033506}],"exchange":"ASX","name":"BIOTRON LIMITED","nameEN":"BIOTRON LIMITED"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-03-05","symbol":"BIT.AU","defaultRemindTime":1741129200000,"type":"split","dateTimestamp":1741093200000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIT.AU\",market:\"AU\",,,undefined,":[]}}